JAKARTA - PT Kresna Graha Investama Tbk (KREN), through its subsidiary, Kresna Biotech Ventures, enriches its digital ecosystem and technology by entering life science and biotechnology sector. Currently, KREN is in the process of finalizing investment plans in several revolutionary companies, including RWDC Industries and Samumed, LLC.
Michael Steven, Founder and CEO of KREN, explained, "KREN, as one of the leading companies in Indonesia in the digital and technology sector, wants to bring the most advanced technology to the people of Indonesia. This will not only enhance our company as an extraordinarily attractive investment opportunity, but also as our company's commitment to bring positive values to the community and the environment."
RWDC Industries is a biotech company that utilizes nature to produce materials used in everyday life. RWDC has a mission to replace oil-based disposable plastics with biodegradable plastics made from safe and sustainable materials. (www.rwdc-industries.com).
Samumed, LLC, a biotech company from San Diego, is one of the leading medical research and development companies for tissue-level regeneration. With the origin of its platform in modulation of small molecule-based Wnt pathways, Samumed developed therapies to treat various degenerative diseases, regenerative medicine and oncology (www.samumed.com). (LM)